Skip to main content
Clinical Trials/PACTR202301861240705
PACTR202301861240705
Not yet recruiting
未知

A prospective clinical and radiological study of incidental cerebral small vessel disease: Aspirin versus Cilostazol (PACCS)

Hany Aref0 sites220 target enrollmentDecember 21, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Nervous System Diseases
Sponsor
Hany Aref
Enrollment
220
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hany Aref

Eligibility Criteria

Inclusion Criteria

  • Patient aged 45 or Above suffering from incidental cerebral SVD
  • Patients presenting with slowly progressive cognitive, urinary, gait abnormalities and/or depression, rather than acute stroke presentation.
  • MRI brain suggestive of small vessel disease in the form of deep white matter hyperintensities (WMH), lacunes, cerebral microbleeds, enlarged Virchow spaces, silent small subcortical infarct

Exclusion Criteria

  • ? Patients with acute onset stroke of any source (Ex: CADASIL)
  • ? Patients with past history of acute large vessel stroke
  • ? Patients with large vessel occlusion or stenosis \>50%
  • ? Contraindication to MRI (as pacemakers or metal plates and screws)
  • ? Alcohol addiction or substance abuse (to exclude substance induced vasculitis)
  • ? Any neurological disease affecting white matter (eg; Multiple sclerosis, sarcoidosis, etc),
  • ? Any neurological disease presenting with symptoms similar to cerebral small vessel disease

Outcomes

Primary Outcomes

Not specified

Similar Trials